Zeng, Zhihong <br/><br/>
Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.  [electronic resource] 

 -  Blood  Jun 2009 
 - 6215-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2008-05-158311  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Chemokine CXCL12--genetics<br/>Chemotaxis--drug effects<br/>Drug Resistance, Neoplasm<br/>Flow Cytometry<br/>Humans<br/>Immunoenzyme Techniques<br/>Leukemia, Experimental--drug therapy<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Mice<br/>Mice, Inbred BALB C<br/>Mutation--genetics<br/>Protein Kinase Inhibitors--pharmacology<br/>Pyridines--pharmacology<br/>Receptors, CXCR4--antagonists & inhibitors<br/>Stromal Cells--drug effects<br/>fms-Like Tyrosine Kinase 3--genetics